Evidence map›Paper›PMID 32193764›Full record

ArticleJournal of gastrointestinal cancer2021

Prevalence of Mismatch Repair-Deficient Colorectal Adenoma/Polyp in Early-Onset, Advanced Cases: a Cross-Sectional Study Based on Iranian Hereditary Colorectal Cancer Registry.

Mahla Rahmani Khorram, Ladan Goshayeshi, Fatemeh Maghool, Robert Bergquist, Kamran Ghaffarzadegan, Saeid Eslami, Alireza Khooei, Benyamin Hoseini

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Journal of gastrointestinal cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Mahla Rahmani KhorramStudent Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Ladan GoshayeshiDepartment of Gastroenterology and Hepatology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Fatemeh MaghoolPoursina Hakim Digestive Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Robert BergquistIngerod, SE-454 94, Brastad, Sweden.
Kamran GhaffarzadeganPathology Department, Education and Research Department, Razavi Hospital, Mashhad, Iran.
Saeid EslamiPharmaceutical Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
Alireza KhooeiDepartment of Pathology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Benyamin HoseiniDepartment of Health Information Technology, Neyshabur University of Medical Sciences, Neyshabur, Iran. Hoseinib1@nums.ac.ir.
Mashhad University of Medical Sciences · IREmam Reza Hospital · IRIsfahan University of Medical Sciences · IRUniversity of Neyshabur · IR

Funding

Mashhad University of Medical Sciences 951047
6 · The paper itself

Abstract

backgroundLynch syndrome (LS) increases the risk of many types of cancer, mainly colorectal cancer (CRC). The purpose of this study was to assess the prevalence of mismatch repair (MMR) deficiency in patients under the age of 50 with advanced adenomatous polyps, aiming at an early diagnosis of LS.

methodsThis retrospective, cross-sectional study included eligible patients with advanced adenomas diagnosed ≤ 50 years of age registered between April 2014 and February 2017 at three pathology centers in Mashhad. Pathological records were reviewed, and colon tissue specimens were analyzed by immunohistochemistry (IHC) staining to identify proteins which serve as markers for LS as they are related to loss of MMR gene (MLH1, MSH2, MSH6, and PMS2) expression.

resultsOf 862 consecutive patients, a total of 50 adenomas (54% males, 46% females of mean age 41.24 ± 6.5) met the eligibility criteria. Of the adenomas examined, 20 (40%) had a tubulovillous component, 34 (68%) had high-grade dysplasia, and 30 (60%) had were larger than 10 mm protrusions. None of the patients had loss of MMR protein expression.

conclusionNo individual with MMR genetic disorder was identified by IHC screening of early-onset advanced colorectal adenomas. This strategy is therefore not an effective strategy for detecting MMR mutation carriers.

Indexed as

DNA Mismatch RepairAdenomatous PolypsAdultAge of OnsetColonColonoscopyColorectal Neoplasms, Hereditary NonpolyposisCross-Sectional StudiesFemaleHeterozygoteHumansImmunohistochemistryIntestinal MucosaIranMaleMedical History TakingAdenomaImmunohistochemistryIranLynch syndromeMismatch repairPolyp

Identifiers

PMID32193764
OpenAlexW3011896613

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.